DB Pharma

What DB Pharma does

DB Pharma (legal name DB PHARMA, doing business as Laboratoires DB Pharma) is a privately-held French pharmaceutical laboratory registered at RCS Créteil B 378 214 886 with a share capital of €225,000, headquartered at 1 bis Avenue du Commandant Rivière, La Varenne Saint Hilaire, 94210 Saint-Maur. The company manufactures and distributes a portfolio of legacy pharmaceutical and dietary products for the French market.

The product catalogue is organized into three categories: medications (11 SKUs including AUREOMYCINE EVANS ophthalmic and topical antibiotics, BECILAN vitamin B6, BEVITINE vitamin B1, BUCCOBET betamethasone buccal tablets, CANTABILINE for dyspepsia, FRUCTINES and RESTRICAL for constipation), dietary products (7 SKUs including APISERUM, BIOLACTYL probiotics, DELBIASE magnesium, GELOPECTOSE for infant feeding, PAPAINE digestive enzymes, and RAPHANUS S.POTIER BIO for hepatobiliary support), and other products (F-TEST forehead thermometer strip and HYDROCLONAZONE water purification tablets). These are primarily established, off-patent formulations targeting niche therapeutic needs — vitamin deficiencies, digestive disorders, minor bacterial infections, and nutritional supplementation.

Commercially, DB Pharma generates revenue through one-time sales of these products distributed via the French pharmacy network, with no publicly disclosed pricing tiers or enterprise contracts. The company operates an institutional bilingual (FR/UK) website providing product information, downloadable RCP technical documentation, and patient leaflets, but maintains no disclosed marketing, partnerships, distribution agreements, headcount, or funding activity in the public source material. The business model is therefore best characterized as a small, niche, single-country specialty pharmaceutical laboratory sustaining a legacy branded portfolio.

Name

DB Pharma

Legal name

DB PHARMA

Website

https://db-pharma.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

DB Pharma is a privately-held French pharmaceutical laboratory that manufactures and distributes a niche portfolio of legacy medications, dietary supplements, and health products through the French pharmacy network. It serves healthcare providers and patients in France with off-patent formulations targeting vitamins, digestion, infections, and nutrition.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Generic Hospital & Institutional Products (HLAIABAL)

Keywords

• Pharmaceutical manufacturing
• Dietary supplements
• Vitamin medications
• Pharmacy distribution
• Specialty therapeutics

Headquarters

HQ city

Saint-maur-des-fossés

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: DB Pharma generates revenue through the manufacture and sale of medications, dietary/nutritional products, and other health-related products distributed primarily through pharmacies in France.

Distribution channels1 record

Marketing channels1 record

Core offering

DB Pharma is a French pharmaceutical laboratory that manufactures and distributes medications, dietary/nutritional products, and ancillary health products through the French pharmacy network. The portfolio spans ophthalmic and topical antibiotics, vitamin B1/B6 supplements, digestive treatments, infant nutritional products, probiotics, water decontamination tablets, and a reusable fever indicator. Products are sold primarily to pharmacies and healthcare providers for patient care in France.

Product overview

DB Pharma is a French pharmaceutical laboratory offering a diversified portfolio of three product categories: Medications (11 products including AUREOMYCINE EVANS, BECILAN, BEVITINE, BUCCOBET, CANTABILINE, FRUCTINES, and RESTRICAL), Dietary Products (7 products including APISERUM FORT BIO, BIOLACTYL, DELBIASE, GELOPECTOSE, PAPAINE, and RAPHANUS S.POTIER BIO), and Other Products (F-TEST and HYDROCLONAZONE). The medications include ophthalmic ointments, vitamin supplements (B1 and B6), anti-inflammatory buccal tablets, and digestive/symptomatic treatments. The dietary products encompass nutritional supplements, probiotics, and special medical foods for infants. The company also provides water treatment products and temperature monitoring tools.

Differentiator

Problem solved

Functional benefit

Products and services

• AUREOMYCINE EVANS 1 % Ophthalmic ointment containing chlortetracycline for local antibacterial treatment of conjunctivitis, keratitis, corneal ulcers, blepharitis, and styes caused by chlortetracycline-sensitive germs, including trachoma treatment.
• AUREOMYCINE EVANS 3 % Topical ointment for treating skin infections caused by Staphylococcus and Streptococcus bacteria.
• BECILAN 250 mg Pyridoxine hydrochloride (Vitamin B6) in 40 scored tablets for treating confirmed Vitamin B6 deficiencies.
• BECILAN 250 mg/5 ml Pyridoxine hydrochloride (Vitamin B6) solution for injection for treating confirmed Vitamin B6 deficiencies when oral administration is not possible.
• BEVITINE 100 mg/2 ml Thiamine hydrochloride (Vitamin B1) injectable solution for treating Vitamin B1 deficiencies when oral administration is not possible.
• BEVITINE 250 mg Thiamine hydrochloride (Vitamin B1) in 20 coated tablets for treating Vitamin B1 deficiency: Beriberi, Wernicke's encephalopathy, as continuation after parenteral treatment.
• BUCCOBET 0,1 mg Betamethasone in 50 sucking tablets for local treatment of inflammation of the oral mucosa and oropharynx.
• CANTABILINE 400 mg Hymecromone in 30 oral tablets for symptomatic treatment of pain associated with dyspeptic disorders.
• FRUCTINES 5 mg Sodium picosulfate in 30 sucking tablets for treating constipation.
• RESTRICAL ESTRAGON Liquid paraffin oral solution for symptomatic treatment of constipation.
• RESTRICAL NOISETTE Liquid paraffin oral solution for symptomatic treatment of constipation.
• APISERUM FORT BIO 1000 Biological Royal Jelly drinkable solution in 24 ampoules/5 ml, a reconstituting nutritional supplement made from natural biological components.
• BIOLACTYL LYOPHILISE Lyophilized living lactic ferments nutritional supplement in oral powder sachets that promotes protection of intestinal flora.
• DELBIASE, comprimé Magnesium supplement in tablets (2 x 24) recommended for magnesium deficiency, as magnesium is involved in neuromuscular function and nerve impulse transmission.
• GELOPECTOSE Special medical food powder containing pectin, cellulose, and colloidal silica for thickening infant formula to prevent regurgitations and reduce diarrhea in infants.
• PAPAINE TROUETTE-PERRET Papaya fruit juice drinkable solution providing natural proteolytic enzymes, used as a support for administration of essential oils.
• PAPAINE TROUETTE-PERRET (sirop) Papaya fruit juice syrup traditionally used for symptomatic treatment of digestive disorders such as epigastric bloating, slow digestion, eructation, and flatulence.
• RAPHANUS S.POTIER BIO Biological phytotherapy supplement in drinkable ampoules for hepatobiliary purposes, traditionally used to facilitate digestion and bile elimination.
• F-TEST Reusable forehead temperature indicator strip, a simple fever test that is unbreakable and safe.
• HYDROCLONAZONE 15 mg Chloramine tablets for oral solution in tubes of 100 or boxes of 1000 for microbiological decontamination of drinking water.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators1 record

Recent moves4 records

Direct peers

• Arrow Génériques: French generics subsidiary of Aurobindo offering a wide portfolio of multisource molecules distributed through French pharmacies. Directly comparable to DB Pharma on product type, therapeutic categories, and pharmacy-channel go-to-market.
• Biogaran: France's leading generics manufacturer and a direct comparator to DB Pharma, distributing a broad portfolio of off-patent molecules through French pharmacies. Both target similar therapeutic categories with established retail pharmacy channels in France.
• Laboratoires Cooper: French specialty pharmaceutical laboratory with a comparable mix of legacy branded generics and OTC products distributed through French pharmacies. Closely aligned with DB Pharma in size, portfolio composition, and therapeutic focus.

Broad incumbents

• Teva Pharmaceuticals: Global generics leader with a substantial French commercial presence across the same off-patent therapeutic categories served by DB Pharma. Overlaps on molecule coverage but at vastly greater scale and geographic reach.
• Laboratoires Pierre Fabre: Large French pharmaceutical and dermo-cosmetics laboratory with broad pharmacy distribution in France. Comparable operating model as a French pharma laboratory serving retail pharmacies, though with a substantially larger portfolio.
• Sanofi: Major French-headquartered pharmaceutical company with a deep French pharmacy footprint spanning prescription, OTC, and consumer health. Overlaps with DB Pharma on certain therapeutic categories and pharmacy-channel distribution.
• Viatris (formerly Mylan): Global generics and specialty pharma company with broad French operations covering many of the same molecules and therapeutic categories as DB Pharma. Operates as a much larger incumbent in the same pharmacy-channel generics market.
• Bayer HealthCare: Global pharmaceutical company with a significant French pharmacy presence including OTC and consumer health products. Overlaps with DB Pharma on pharmacy-channel distribution and certain therapeutic categories.
• Boiron: French pharmaceutical laboratory distributing a broad portfolio of health products through French pharmacies. Shares the laboratoire business model and French pharmacy-channel go-to-market with DB Pharma, though focused on homeopathic specialties.
• Laboratoires Urgo: French pharmaceutical laboratory specializing in wound care, oral care, and OTC products distributed through French pharmacies. Operates a similar laboratory-to-pharmacy model with branded specialty products.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/db-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DB Pharma